These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20442291)

  • 1. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
    Lee CW; Ito K; Ito Y
    Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
    Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
    Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress induces proliferation of colorectal cancer cells by inhibiting RUNX3 and activating the Akt signaling pathway.
    Kang KA; Kim KC; Bae SC; Hyun JW
    Int J Oncol; 2013 Nov; 43(5):1511-6. PubMed ID: 24042352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers.
    Ito K
    J Cell Biochem; 2011 May; 112(5):1243-9. PubMed ID: 21465522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
    Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
    Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
    Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
    Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
    Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells.
    Palcy S; Bolivar I; Goltzman D
    J Bone Miner Res; 2000 Dec; 15(12):2352-61. PubMed ID: 11127200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
    Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
    J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.
    Torquati A; O'rear L; Longobardi L; Spagnoli A; Richards WO; Daniel Beauchamp R
    Surgery; 2004 Aug; 136(2):310-6. PubMed ID: 15300196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K; Kumagai T; Shimizu T; Takeda K
    Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runx3 negatively regulates Osterix expression in dental pulp cells.
    Zheng L; Iohara K; Ishikawa M; Into T; Takano-Yamamoto T; Matsushita K; Nakashima M
    Biochem J; 2007 Jul; 405(1):69-75. PubMed ID: 17352693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer.
    Schwalbe M; Sänger J; Eggers R; Naumann A; Schmidt A; Höffken K; Clement JH
    Int J Oncol; 2003 Jul; 23(1):89-95. PubMed ID: 12792780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
    Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
    Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runx3 expression during mouse tongue and palate development.
    Yamamoto H; Ito K; Kawai M; Murakami Y; Bessho K; Ito Y
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Jul; 288(7):695-9. PubMed ID: 16761282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
    Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
    Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.